Target：YIPF3
Gene Name：YIPF3 C6orf109 KLIP1
Protein Name：Protein YIPF3 (Killer lineage protein 1) (Natural killer cell-specific antigen KLIP1) (YIP1 family member 3) [Cleaved into: Protein YIPF3, 36 kDa form III]
Human Gene Id：25844
Human Swiss Prot No：Q9GZM5
Mouse Swiss Prot No：Q3UDR8
Rat Swiss Prot No：Q6TUD4
Immunogen：Synthesized peptide derived from human protein . at AA range: N-terminal
Specificity：YIPF3 Polyclonal Antibody detects endogenous levels of protein.
Formulation：Liquid in PBS containing 50% glycerol, and 0.02% sodium azide.
Source：Polyclonal, Rabbit,IgG
Dilution：WB 1:500-2000 ELISA 1:5000-20000
Purification：The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration：1 mg/ml
Storage Stability：-15°C to -25°C/1 year(Do not lower than -25°C)
Observed Band(KD)：38kD
Background：developmental stage:Expressed in fetal liver (at protein level). Expressed in embryonic hematopoiesis sites.,function:May play a role in hematopoiesis.,PTM:Not glycosylated.,similarity:Belongs to the YIP1 family.,subcellular location:Localization to the cytoplasm or to the cell membrane is developmentally and ontogenetically regulated.,tissue specificity:Expressed by nucleated hematopoietic cells (at protein level).,
Function：developmental stage:Expressed in fetal liver (at protein level). Expressed in embryonic hematopoiesis sites.,function:May play a role in hematopoiesis.,PTM:Not glycosylated.,similarity:Belongs to the YIP1 family.,subcellular location:Localization to the cytoplasm or to the cell membrane is developmentally and ontogenetically regulated.,tissue specificity:Expressed by nucleated hematopoietic cells (at protein level).,
Subcellular Location：Cell membrane; Multi-pass membrane protein. Cytoplasm. Golgi apparatus, cis-Golgi network membrane ; Multi-pass membrane protein. Localization to the cytoplasm or to the cell membrane is developmentally and ontogenetically regulated.
Expression：Expressed by nucleated hematopoietic cells (at protein level).
